Abstract 6267: Repurposing antiandrogens to overcome therapy resistance in androgen receptor-positive glioblastoma

MLA

Sriram Venneti, et al. “Abstract 6267: Repurposing Antiandrogens to Overcome Therapy Resistance in Androgen Receptor-Positive Glioblastoma.” Cancer Research, vol. 80, Aug. 2020, p. 6267. EBSCOhost, https://doi.org/10.1158/1538-7445.am2020-6267.

APA

Sriram Venneti, Roy E. Strowd, Corey Speers, Stefanie Stallard, Arul Chinnayain, Hanshi Sun, Jann N. Sarkaria, Carl Koschmann, Arvind Rao, Edwina Baskin-Bey, Joseph Dresser, Christian K. Werner, Daniel E. Spratt, Meredith A. Morgan, Alexander M. Hegedus, Howard Colman, Daniel R. Wahl, Weihua Zhou, Theodore S. Lawrence, … Yangyang Yao. (2020). Abstract 6267: Repurposing antiandrogens to overcome therapy resistance in androgen receptor-positive glioblastoma. Cancer Research, 80, 6267. https://doi.org/10.1158/1538-7445.am2020-6267

Chicago

Sriram Venneti, Roy E. Strowd, Corey Speers, Stefanie Stallard, Arul Chinnayain, Hanshi Sun, Jann N. Sarkaria, et al. 2020. “Abstract 6267: Repurposing Antiandrogens to Overcome Therapy Resistance in Androgen Receptor-Positive Glioblastoma.” Cancer Research 80 (August): 6267. doi:10.1158/1538-7445.am2020-6267.